Gender disparities in chemotherapy use and survival in patients with metastatic bladder cancer (BCa).

被引:3
|
作者
Rose, Tracy Lynn
Deal, Allison Mary
Yang, Hojin
Nielsen, Matthew Edward
Smith, Angela
Milowsky, Matthew I.
机构
[1] UNC Hosp, Durham, NC USA
[2] UNC Lineberger Comprehens Canc Center, Biostat Core Facil, Chapel Hill, NC USA
[3] Univ N Carolina, Chapel Hill, NC USA
[4] UNC Chapel Hill Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
关键词
D O I
10.1200/jco.2015.33.15_suppl.e15508
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e15508
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Sex disparities in use of chemotherapy and survival in patients with advanced bladder cancer
    Rose, Tracy L.
    Deal, Allison M.
    Nielsen, Matthew E.
    Smith, Angela B.
    Milowsky, Matthew I.
    CANCER, 2016, 122 (13) : 2012 - 2020
  • [2] Sociodemographic disparities in chemotherapy treatment and impact on survival among patients with metastatic bladder cancer
    Klapheke, Amy
    Yap, Stanley A.
    Pan, Kevin
    Cress, Rosemary D.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (06) : 308.e19 - 308.e25
  • [3] Gender Disparities in Metastatic Colorectal Cancer Survival
    Hendifar, Andrew
    Yang, Dongyun
    Lenz, Felicitas
    Lurje, Georg
    Pohl, Alexandra
    Lenz, Cosima
    Ning, Yan
    Zhang, Wu
    Lenz, Heinz-Josef
    CLINICAL CANCER RESEARCH, 2009, 15 (20) : 6391 - 6397
  • [4] Efficacy of chemotherapy on overall survival in metastatic sarcomatoid bladder cancer patients
    Tappero, Stefano
    Sorce, Gabriele
    Panunzio, Andrea
    Hohenhorst, Lukas
    Garcia, Cristina Cano
    Piccinelli, Mattia Luca
    Tian, Zhe
    Parodi, Stefano
    Chun, Felix K. H.
    Graefen, Markus
    Antonelli, Alessandro
    De Cobelli, Ottavio
    Saad, Fred
    Shariat, Shahrokh F.
    Montorsi, Francesco
    Suardi, Nazareno R.
    Borghesi, Marco
    Terrone, Carlo
    Karakiewicz, Pierre I.
    CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2022, 75 (04) : 352 - 356
  • [5] Nationwide trends in chemotherapy use and survival of elderly patients with metastatic pancreatic cancer
    van der Geest, Lydia G. M.
    Mohammad, Nadia Haj
    Besselink, Marc G. H.
    Lemmens, Valery E. P. P.
    Portielje, Johanneke E. A.
    van Laarhoven, Hanneke W. M.
    Wilmink, J. W.
    CANCER MEDICINE, 2017, 6 (12): : 2840 - 2849
  • [6] Nationwide trends in chemotherapy use and survival of elderly patients with metastatic pancreatic cancer
    Van der Geest, L. G. M.
    Mohammad, N. Haj
    Besselink, M. G. H.
    Lemmens, V. E. P. P.
    Portielje, J. E. A.
    Van Laarhoven, H. W. M.
    Wilmink, J. W.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S86 - S86
  • [7] Neoadjuvant Chemotherapy in Ovarian Cancer: Are There Racial Disparities in Use and Survival?
    Amin, Saber A.
    Collin, Lindsay J.
    Setoguchi, Soko
    Satagopan, Jaya M.
    de Meritens, Alexandre Buckley
    Bandera, Elisa V.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (02) : 175 - 182
  • [8] Chemotherapy for metastatic bladder cancer
    Roberts, JT
    CLINICAL ONCOLOGY, 2005, 17 (07) : 514 - 523
  • [9] RACIAL AND ECONOMIC DISPARITIES IN THE USE OF NEOADJUVANT CHEMOTHERAPY FOR PATIENTS WITH UROTHELIAL MUSCLE INVASIVE BLADDER CANCER
    Robins, Dennis
    Suss, Nicholas
    Flores, Viktor
    Smith, Matthew
    Weiss, Jeffrey
    McNeil, Brian
    Winer, Andrew
    JOURNAL OF UROLOGY, 2019, 201 (04): : E359 - E359
  • [10] CHEMOTHERAPY AND SURVIVAL IN PATIENTS WITH URINARY-BLADDER CANCER
    ALSARRAF, M
    AMER, MH
    VAITKEVICIUS, VK
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 116 - 116